Titre:
  • Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study
Auteur:Reinhart, Konrad; Menges, Thilo; Gardlund, Bengt; Zwaveling, JanHarm; Smithes, Mark; Vincent, Jean Louis; Tellado, Jose Maria; Salgado-Remigio, Antonio; Zimlichman, Reuven; Withington, Stuart; Tschaikowsky, Klaus; Brase, Rainer; Damas, Pierre; Kupper, Hartmut; Kempeni, Joachim; Eiselstein, Juergen; Kaul, Martin
Informations sur la publication:Critical care medicine, 29, 4, page (765-769)
Statut de publication:Publié, 2001
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Clinical trial
Critical illness
Cytokines
Infection
Interleukin-6
Monoclonal antibody
Sepsi
Septic shock
Tumor necrosis factor
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0090-3493
info:scp/0035046049